RHEUMATOID ARTHRITIS Obesity impairs efficacy of anti-TNF therapy in patients with RA

被引：18

作者：

Gonzalez-Gay, Miguel A. ^{[1
]}

Gonzalez-Juanatey, Carlos ^{[2
]}

机构：

[1] Hosp Univ Marques de Valdecilla, IFIMAV, Div Rheumatol, Santander 39008, Spain

[2] Hosp Univ Lucus Augusti, Div Cardiol, Lugo 27003, Spain

来源：

NATURE REVIEWS RHEUMATOLOGY | 2012年 / 8卷 / 11期

关键词：

INSULIN-RESISTANCE; SENSITIVITY;

D O I：

10.1038/nrrheum.2012.158

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Insulin resistance is closely associated with an increased risk of subclinical atherosclerosis in patients with rheumatoid arthritis (RA). Anti-TNF therapy reduces insulin resistance and improves insulin sensitivity in patients with severe RA. New findings have shown, however, that the efficacy of these agents in this regard is impaired by obesity. Gonzalez-Gay, M. A. & Gonzalez-Juanatey, C. Nat. Rev. Rheumatol. 8, 641-642 (2012); published online 25 September 2012; doi:10.1038/nrrheum.2012.158

引用

页码：641 / 642

页数：3

共 50 条

[31] Application of omics in predicting anti-TNF efficacy in rheumatoid arthritis
Xie, Xi
Li, Fen
Li, Shu
Tian, Jing
Chen, Jin-wei
Du, Jin-feng
Mao, Ni
Chen, Jian
CLINICAL RHEUMATOLOGY, 2018, 37 (01) : 13 - 23
[32] THE IMPACT OF ANTI-TNF ON THE WEIGHT OF RHEUMATOID ARTHRITIS PATIENTS
Alcorn, Nicola
Tierney, Ann
Wu, Olivia
Gilmour, Harper
Capell, Hillary
Madhok, Rajan
RHEUMATOLOGY, 2009, 48 : I63 - I63
[33] Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis
Coenen, Marieke J. H.
Toonen, Erik J. M.
Scheffer, Hans
Radstake, Timothy R. D. J.
Barrera, Pilar
Franke, Barbara
PHARMACOGENOMICS, 2007, 8 (07) : 761 - 773
[34] FRACTURE RISK ASSESSMENT (FRAX) IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THERAPY WITH ANTI-TNFα
Anghel, D.
Otlocan, L.
Negru, M. M.
Busuioc, E.
Bursuc, R.
Smedescu, V.
Manolache, A.
Jurcut, C.
OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S400 - S400
[35] Anti-TNF therapy does not suppress TST response in rheumatoid arthritis patients
Medina, F
Ramirez, R
Hernandez, R
Portela, M
Barile, L
Fuentes, J
Fraga, A
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 409 - 409
[36] Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity
Hyrich, Kimme L.
Deighton, Chris
Watson, Kath D.
Symmons, Deborah P. M.
Lunt, Mark
RHEUMATOLOGY, 2009, 48 (10) : 1323 - 1327
[37] Influence of anti-TNF alpha therapy on lipid profile in rheumatoid arthritis patients
Bernardes, M.
Martins, E.
Bernardo, A.
Cardoso, L.
Simoes-Ventura, F.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 176 - 177
[38] PATIENT EXPERIENCE WITH SUBCUTANEOUS ANTI-TNF THERAPY AMONG RHEUMATOID ARTHRITIS PATIENTS
Tandon, N.
Bolge, S.
Annunziata, K.
VALUE IN HEALTH, 2011, 14 (03) : A134 - A134
[39] Patients' perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative study
Marshall, NJ
Wilson, G
Lapworth, K
Kay, LJ
RHEUMATOLOGY, 2004, 43 (08) : 1034 - 1038
[40] Infections in Patients With Rheumatoid Arthritis Undergoing Anti-TNF alpha Drug Therapy
Alonso Ruiz, Alberto
REUMATOLOGIA CLINICA, 2008, 4 : 18 - 23

← 1 2 3 4 5 →